NII Holdings, Inc. NIHD
We initially tagged NIHD in our premarket report from last Thursday, and on that day we would observe a low of .5472 in the stock. It’s been stepping its way up, but this morning in premarket trading things have really kicked into high gear, with NIHD cracking through the dollar barrier.
As of this morning’s premarket high of 1.14, we’ve now witnessed an increase of 108% in NIHD over a span of just three trading sessions. In order for us to remain highly interested in this play, we’ll want to see it maintain support at or above its current 50DMA of .83 on any pullbacks that may occur.
Celsion Corp. CLSN
We called out CLSN in yesterday morning’s premarket report, and saw a modest yet respectable move out of that play as well. From a low of 3.85 the stock ran as high as 4.96, marking an intraday move of 29%
The stock was number four on the NASDAQ’s top gainer list for the day, and while it did end up tapering back to close near its daily lows, this morning it is gapping up again in the premarket. This surge of activity is primarily due to yesterday’s announcement of positive results in its ovarian cancer treatment trials.
We’ll definitely be keeping CLSN on our radars and watching for the continued establishment of higher lows off of our recently observed bottom.
Bitcoin Services, Inc. BTSC
BTSC was a part of the bitcoin watchlist we issued on May 25th in the midst of a bitcoin frenzy where the crypto-currency was soaring to new all-time highs.
The residual effect for plays like BTSC has been impressive, with with stocks PPS making a jump from our observed low of .0366 up to a new high of .164 yesterday, which represents a 348% rip which occurred over a period of just seven sessions.
Egalet Corp. EGLT
Not only is EGLT coming off of a bottom on the chart, but in the space of the past 36 hours, the company has made two major announcements.
Yesterday, it was made known that EGLT had “received a U.S. patent for its proprietary Guardian™ Technology tablet architecture used to create precise delivery of combination products with immediate-, delayed- and/or extended-release properties.” (>>View PR)
Today, the announcement was that “one of the largest payers in the United States will provide coverage of ARYMO® ER (morphine sulfate) extended-release tablets” (>>View PR)
Extended Watchlist:
KMI, GAHC, EBIO, GALT, IAG, BLDP, SBGL